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Accepted 12 March 2003In systematic reviews statistical pooling is not always
possible due to inadequate reporting of the results of original
studies. In these reviews, a qualitative analysis using levels
of evidence may be performed to summarize the evidence
and to formulate conclusions [1]. This is explicit and repro-
ducible, because it explains the exact meaning of labels like
strong, moderate, and limited evidence. In the course of
time, different sets of levels of evidence have been published
[2–5]. All these sets are arbitrary and based on common
sense at best. Ferreira et al. [6] show in their article that
these different criteria may lead to different conclusions.
They advise readers to be cautious when interpreting conclu-
sions of systematic reviews that use levels of evidence. We
fully agree, but not merely because different sets of criteria
exist. If only one set of levels of evidence would exist this
warning would even be more necessary. The use of levels of
evidence is essentially an arbitrary and subjective way
of summarizing evidence. Typically levels of evidence take
into account the quality of the studies and the consistency of
the results. In contrast to meta-analysis (statistical pooling),
levels of evidence do not include the size of the effect. In
the interpretation of both the conclusions of a study and its
methodologic quality, there is some subjectivity involved.
For example, grading the conclusions is difficult when there
is borderline statistical significance, when a positive effect is
observed for only part of many outcome measures studied,
or when the reviewers do not agree with the authors’ con-
clusions.
A similar example of arbitrary definitions is the interpreta-
tion of kappa values. Ferreira et al. [6] use the benchmarks
proposed by Landis and Koch [7] to interpret their kappa
values. Other often-used benchmarks are the ones proposed
by Fleiss [8], which would have changed the conclusions
about the disagreements between different sets of levels of
evidence in Fereirra’s paper [6] slightly. Existence of differ-
ent rating systems emphasizes their subjectivity. Kappa
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absolute interpretation would give false certainty. Another
illustrative example in the field of systematic reviews is
the existence of many different instruments to measure the
methodologic quality of a randomized clinical trial. Jüni et
al. [10] applied 25 different quality instruments to the same
review and found that the conclusion of the review was
dependent on the quality instrument that was used. Of course,
in a review with convincing and indisputable results the con-
clusion will be the same regardless of the quality instruments
and the set of levels of evidence used. Sensitivity analysis to
study the robustness of the conclusions of a systematic
review, as both Ferreira et al. [6] and Jüni et al. [10] suggest,
is an advisable solution.
The most striking observation in the article of Ferreira
et al. [6] is that the different levels of evidence came from
the same research institute [1,2–4]. This illustrates how
arbitrary the levels of evidence are, and the difficulty we
had in reaching consensus. Recently, we proposed levels of
evidence for reviews with incomplete statistical pooling, but
also these are arbitrary [11].
An interesting question is whether levels of evidence
should be the same for all situations. Less stringent rules
for evidence could be proposed for situations in which there
is an urgent need for an effective therapy and very stringent
rules in fields where an abundance of effective therapies
exists. In these latter fields one wants to be quite sure whether
an additional therapy is really more effective than all ex-
isting ones.
In our opinion, the existence of different sets of levels
of evidence is not alarming, and emphasizes the essential
relativity. However, we recognize the disadvantage that re-
viewers may be tempted to choose the set of criteria that
gives them the most favorable conclusions. Therefore, within
the field of low back pain the Cochrane Back Review Group
has recently acknowledged the need for standardization and
included a proposal for a specific rating system in the update
of the method guidelines for systematic reviews in the field
of back pain [12].
H.C.W. de Vet et al / Journal of Clinical Epidemiology 56 (2003) 917–918918References
[1] Van Tulder M, Koes BW, Bouter LM. Conservative treatment of acute
and chronic non specific low back pain. A systematic review of
randomized controlled trials of the most common interventions. Spine
1997;22:2128–56.
[2] Van Tulder MW, Ostelo R, Vlaeyen JWS, Linton SJ, Morley SJ,
Assendelft WJJ. Behavioural treatment for chronic low back pain: a
systematic review within the framework of the Cochrane Collabo-
ration Back Review Group. Spine 2000;25:2688–99.
[3] Van Poppel MNM, Koes BW, Smid T, Bouter LM. A systematic
review of controlled clinical trials on the prevention of low back pain
in industry. Occup Environ Med 1997;54:841–47.
[4] Van der Windt DAWN, Van der Heijden GJMG, Van der Berg SGM, Ter
Riet G, De Winter AF, Bouter LM. Ultrasound therapy for musculo-
skeletal disorders: a systematic review. Pain 1999;81:257–71.
[5] Berghmans LCM, Hendriks HJM, Bo K, Hay -Smith EJ, De Bie RA,
Van Doorn ESCVW. Conservative treatment of stress urinary inconti-
nence in women: a systematic review of randomised clinical trials.
Br J Urol 1998;82:181–91.[6] Ferreira PH, Ferreira ML, Maher CG, Refshauge K, Herbert RD,
Latimer J. Effect of applying different “levels of evidence” criteria
on conclusions of Cochrane reviews of interventions for low back
pain. J Clin Epidemiol 2002;55:1126–9.
[7] Landis JR, Koch GG. The measurement of observer agreement for
categorical data. Biometrics 1997;33:159–74.
[8] Fleiss JL. The design and analysis of clinical experiments. New York:
John Wiley & Sons; 1986.
[9] Feinstein AR, Cicchetti D. High agreement but low kappa: I. The
problem of two paradoxes. J Clin Epidemiol 1990;43:543–9.
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